Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study. - Wikidata - wikimedia - TriplyDB

Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.

Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.

http://www.wikidata.org/entity/Q54327711

about

Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis Early diagnosis of pancreatic cancer: challenges and new developments Pancreatic cancer: Are "liquid biopsies" ready for prime-time?Biomarkers in pancreatic adenocarcinoma: current perspectives Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer The Potential for Circulating Tumor Cells in Pancreatic Cancer Management.Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients.Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.Ultra-Specific Isolation of Circulating Tumor Cells Enables Rare-Cell RNA Profiling Optical Aptamer Probes of Fluorescent Imaging to Rapid Monitoring of Circulating Tumor Cell.MUC1 and metastatic cancer: expression, function and therapeutic targeting.Analysis of circulating tumor cells from lung cancer patients with multiple biomarkers using high-performance size-based microfluidic chip Plasticity of disseminating cancer cells in patients with epithelial malignancies.New biomarkers and targets in pancreatic cancer and their application to treatment.Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications.Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology.Enrichment, detection and clinical significance of circulating tumor cells.Biomarkers for early diagnosis of pancreatic cancer.Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.Gene expression profiling and DNA methylation analyses of CTCs.Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations.A Speculative Role for Stromal Gastrin Signaling in Development and Dissemination of Pancreatic Ductal Adenocarcinoma Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma.Identification of candidate genes related to pancreatic cancer based on analysis of gene co-expression and protein-protein interaction network Comment on Han L et al.: prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis.EpCAM-based Flow Cytometric Detection of Circulating Tumor Cells in Gallbladder Carcinoma Cases Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.Aptamer-functionalized nano/micro-materials for clinical diagnosis: isolation, release and bioanalysis of circulating tumor cells.Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.Circulating molecular markers in pancreatic cancer: ready for clinical use?Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?KRAS mutations in pancreatic circulating tumor cells: a pilot study.

P2860

Q26739062-BCCCCE88-8659-4EE2-BCD4-2C40274E8A7E Q26781333-82C1DFC4-0801-41F6-B923-0170933FEBB5 Q26782719-0256945E-BBB6-415D-BA34-7D2A41335368 Q27014027-FE14F083-E169-4FA7-9DEF-EABB2F9DAFA6 Q28068665-1ADDD416-23BE-4FE1-A086-CE14E404C1AA Q28072309-DB879492-1D90-4F8A-8182-3EABAAEF9B25 Q28073765-AA90995B-CC9B-404E-8F2A-4A85D43A21D5 Q33753267-E77DAC4D-8FBC-4C16-9B74-4DDD4E9EDDA2 Q33803923-F7B16CB1-CA41-44B4-A6AB-8E89783B4672 Q35039154-8813920C-4934-454C-873E-A2C7B3100DD7 Q35752053-C398E3E9-B460-4D70-82D5-63DE783D63AE Q36430451-AFC4F6DB-8088-492D-8DBA-12BA16964E5B Q36790514-3648E8D6-AF76-4092-AE7E-C670059D322B Q37075334-12687E64-8E92-4435-BBE1-7BC12DD69E25 Q37291876-3DC73FDA-67F1-4F56-B1AC-8B222C1B67A5 Q37467334-CF80D590-DF17-424C-94ED-9F8CA5C6DB77 Q37636939-ACAB1892-A6D3-4D70-9305-AC4976545C65 Q37706522-3B59540C-A5B8-4280-A55F-1C1B3738EB6F Q38021683-6BC36928-821B-4EAB-AF6C-8A64A5A21598 Q38021692-74B08581-259A-4BAF-9B5A-F38ECA707A6E Q38085263-683C868D-D7B8-40BC-AACC-A6AB8F232E81 Q38085411-C7565AF7-15A4-4CEE-B367-B8F8BC2898B0 Q38102590-69A304A9-7EE9-4A4E-A9E3-F7C6BBC4C97C Q38265405-3665CBE9-326B-438F-8D01-A4F027E04AC2 Q38726457-BB41ACC1-D0ED-452B-95BB-F865B1AF3E7C Q38734877-292458BE-4B0F-41C3-816A-E30487A61A9E Q40136040-44537D79-AF16-416F-A31F-2FF2F0FEABDB Q41902545-88841944-FE71-49E3-9EB7-BA24A262F4A2 Q42040315-F98BAC9A-C75A-4CEE-9678-B8755B472A32 Q42378509-8700F73A-4AD3-4863-AFB5-31392FEA923F Q43795070-B26B67A8-06D1-487C-818E-E20A09A53731 Q47146321-AAA9094D-0910-4F89-876B-BE48370F8805 Q49496843-2792615F-CC7E-4C61-987D-522E203F990F Q50016747-0B8F607F-4843-4AF8-B926-1D58B1EAA1ED Q51022761-3A63D847-74A2-4796-BEBB-7282D77A1DC3 Q51445413-B4A8D5DB-721F-4E03-AC63-1AE9F67A2468 Q51498128-11EF5309-BDF3-49BF-8586-F47C3950EABC Q52595056-E085AD07-B426-4FA7-92B3-D03FD7AA312A Q52739894-578745F9-CD68-4398-87ED-BA5CC9353EDB Q53238634-6DA3D74F-6ADB-4447-BFE2-0BD2D3022EDB

P2860

Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.

http://www.wikidata.org/entity/Q54327711

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Multimarker gene analysis of c ...... patients: a feasibility study.

@en

Multimarker gene analysis of c ...... patients: a feasibility study.

@nl

type

label

Multimarker gene analysis of c ...... patients: a feasibility study.

@en

Multimarker gene analysis of c ...... patients: a feasibility study.

@nl

prefLabel

Multimarker gene analysis of c ...... patients: a feasibility study.

@en

Multimarker gene analysis of c ...... patients: a feasibility study.

@nl

P1433

Q54327711-FFCB8F1E-84D3-4CE8-BE3C-F691AC085A67

P1476

Q54327711-BFDA11EB-5334-4981-9A6B-766193479756

P2093

Q54327711-135B8387-0832-4FE0-B422-F060F754C7DF

Q54327711-1B91A40C-26D2-46FA-B914-1ED2261F6744

Q54327711-6DAB7655-D745-4437-965D-F482385F29EF

Q54327711-781D4CA5-911C-4F1B-BE58-287B11A4E040

Q54327711-8842227D-2A1B-4E45-9CF6-B6A01C9FCAB8

Q54327711-C2C28BE6-35E8-4598-AFB6-2823072E0DD2

Q54327711-EC688960-AC86-4B8F-810D-00E8DF43B12C

P2860

Q54327711-0C2E6320-FD35-4B9B-A82E-63F4958BAF92

Q54327711-15D573E6-2E72-4340-9343-2058A097BE70

Q54327711-1A16A91C-CAC2-49FA-82D0-D3F6675B12FB

Q54327711-1A8E8C25-9F8C-4550-99E1-47DFC90B7726

Q54327711-1B2A12B8-DE53-4D96-B2C2-4A009E0EF3FB

Q54327711-282B8C0C-D089-4B2F-9D80-BB71E5E69ED4

Q54327711-2967F92A-4AD4-449A-8644-B5D604A1FE19

Q54327711-525B22B7-76BD-4545-9D8E-448C46717BC9

Q54327711-578A6486-8913-4433-9D63-1FC351F4896E

Q54327711-59541318-2ADC-4FF9-9916-6112BF083D9F

P304

Q54327711-1FCCBF5A-1D67-4E92-BD7A-543A453F879F

P31

Q54327711-38AD93A7-F1BC-472A-B6AD-9DAF52BC2A23

P356

Q54327711-FB4BCD86-00E1-4256-90CC-673746F26414

P433

Q54327711-0249E6E8-F2BE-45DF-B1A3-74D2BDA03BF1

P478

Q54327711-8CEF2B99-C6D4-4A7C-8AB1-3AB5BE3BCAE9

P50

Q54327711-B64C10DC-B8E4-4FCF-B61B-7769F70F2574

P577

Q54327711-CEA1F5D3-A03E-4B9C-9254-18676C07C462

P5875

Q54327711-A4EC37CB-8680-4541-ACCB-A3B6EC950331

P698

Q54327711-8CF3C12F-7255-43E0-8461-DB744EBFE3F7

P921

Q54327711-47C7215C-E302-417D-BF21-910B1D0D7460

P356

P1433

P1476

Multimarker gene analysis of c ...... patients: a feasibility study

@en

P2093

Andreia de Albuquerque

http://www.w3.org/2001/XMLSchema#string

Astrid Eichler

http://www.w3.org/2001/XMLSchema#string

Gudrun Stamminger

http://www.w3.org/2001/XMLSchema#string

Ilja Kubisch

http://www.w3.org/2001/XMLSchema#string

Nikos Fersis

http://www.w3.org/2001/XMLSchema#string

Sepp Kaul

http://www.w3.org/2001/XMLSchema#string

Ulrich Stölzel

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of rare circulating tumour cells in cancer patients by microchip technology

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition

Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

Frequent EpCam protein expression in human carcinomas

Cancer statistics, 2007

Cancer statistics, 2009

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.

P304

3-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000335479

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221770839

http://www.w3.org/2001/XMLSchema#string

P698

22270149

http://www.w3.org/2001/XMLSchema#string

P921

Feasibility study